Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 701

1.

De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry.

Passioura T, Watashi K, Fukano K, Shimura S, Saso W, Morishita R, Ogasawara Y, Tanaka Y, Mizokami M, Sureau C, Suga H, Wakita T.

Cell Chem Biol. 2018 Jul 19;25(7):906-915.e5. doi: 10.1016/j.chembiol.2018.04.011. Epub 2018 May 17.

PMID:
29779957
2.

A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.

Saso W, Tsukuda S, Ohashi H, Fukano K, Morishita R, Matsunaga S, Ohki M, Ryo A, Park SY, Suzuki R, Aizaki H, Muramatsu M, Sureau C, Wakita T, Matano T, Watashi K.

Biochem Biophys Res Commun. 2018 Jun 22;501(2):374-379. doi: 10.1016/j.bbrc.2018.04.187. Epub 2018 May 11.

PMID:
29730285
3.

Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery Disease.

Sanada F, Taniyama Y, Muratsu J, Otsu R, Shimizu H, Rakugi H, Morishita R.

Medicines (Basel). 2018 Mar 30;5(2). pii: E31. doi: 10.3390/medicines5020031. Review.

4.

Source of Chronic Inflammation in Aging.

Sanada F, Taniyama Y, Muratsu J, Otsu R, Shimizu H, Rakugi H, Morishita R.

Front Cardiovasc Med. 2018 Feb 22;5:12. doi: 10.3389/fcvm.2018.00012. eCollection 2018.

5.

Therapeutic Vaccines for Hypertension: a New Option for Clinical Practice.

Nakagami H, Morishita R.

Curr Hypertens Rep. 2018 Mar 19;20(3):22. doi: 10.1007/s11906-018-0820-z. Review.

PMID:
29556794
6.

IGF Binding Protein-5 Induces Cell Senescence.

Sanada F, Taniyama Y, Muratsu J, Otsu R, Shimizu H, Rakugi H, Morishita R.

Front Endocrinol (Lausanne). 2018 Feb 20;9:53. doi: 10.3389/fendo.2018.00053. eCollection 2018. Review.

7.

Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer.

Nakazawa Y, Taniyama Y, Sanada F, Morishita R, Nakamori S, Morimoto K, Yeung KT, Yang J.

Sci Rep. 2018 Mar 5;8(1):4013. doi: 10.1038/s41598-018-22340-7.

8.

Prevention of Asthma Exacerbation in a Mouse Model by Simultaneous Inhibition of NF-κB and STAT6 Activation Using a Chimeric Decoy Strategy.

Miyake T, Miyake T, Sakaguchi M, Nankai H, Nakazawa T, Morishita R.

Mol Ther Nucleic Acids. 2018 Mar 2;10:159-169. doi: 10.1016/j.omtn.2017.12.005. Epub 2017 Dec 14.

9.

Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice.

Kawakami R, Nozato Y, Nakagami H, Ikeda Y, Shimamura M, Yoshida S, Sun J, Kawano T, Takami Y, Noma T, Rakugi H, Minamino T, Morishita R.

PLoS One. 2018 Feb 13;13(2):e0191895. doi: 10.1371/journal.pone.0191895. eCollection 2018.

10.

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.

Kaneko M, Futamura Y, Tsukuda S, Kondoh Y, Sekine T, Hirano H, Fukano K, Ohashi H, Saso W, Morishita R, Matsunaga S, Kawai F, Ryo A, Park SY, Suzuki R, Aizaki H, Ohtani N, Sureau C, Wakita T, Osada H, Watashi K.

Sci Rep. 2018 Feb 9;8(1):2769. doi: 10.1038/s41598-018-20987-w.

11.

Local Production of Activated Factor X in Atherosclerotic Plaque Induced Vascular Smooth Muscle Cell Senescence.

Sanada F, Muratsu J, Otsu R, Shimizu H, Koibuchi N, Uchida K, Taniyama Y, Yoshimura S, Rakugi H, Morishita R.

Sci Rep. 2017 Dec 7;7(1):17172. doi: 10.1038/s41598-017-17508-6.

12.

Association between renin-angiotensin-aldosterone system blockade and future osteoporotic fracture risk in hypertensive population: A population-based cohort study in Taiwan.

Chen CI, Yeh JS, Tsao NW, Lin FY, Shih CM, Chiang KH, Kao YT, Fang YA, Tsai LW, Liu WC, Nakagami H, Morishita R, Kuo YJ, Huang CY.

Medicine (Baltimore). 2017 Nov;96(46):e8331. doi: 10.1097/MD.0000000000008331.

13.

Inhibition of Aneurysm Progression by Direct Renin Inhibition in a Rabbit Model.

Miyake T, Miyake T, Shimizu H, Morishita R.

Hypertension. 2017 Dec;70(6):1201-1209. doi: 10.1161/HYPERTENSIONAHA.117.09815. Epub 2017 Oct 23.

PMID:
29061718
14.

Observation by Real-Time NMR and Interpretation of Length- and Location-Dependent Deamination Activity of APOBEC3B.

Wan L, Nagata T, Morishita R, Takaori-Kondo A, Katahira M.

ACS Chem Biol. 2017 Nov 17;12(11):2704-2708. doi: 10.1021/acschembio.7b00662. Epub 2017 Oct 3.

PMID:
28952713
15.

Expression analyses of Phactr1 (phosphatase and actin regulator 1) during mouse brain development.

Ito H, Mizuno M, Noguchi K, Morishita R, Iwamoto I, Hara A, Nagata KI.

Neurosci Res. 2018 Mar;128:50-57. doi: 10.1016/j.neures.2017.08.002. Epub 2017 Aug 10.

PMID:
28803787
16.

Identification and characterization of a centrosomal protein, FOR20 as a novel S100A6 target.

Sakane K, Nishiguchi M, Denda M, Yamagchi F, Magari M, Kanayama N, Morishita R, Tokumitsu H.

Biochem Biophys Res Commun. 2017 Sep 30;491(4):980-985. doi: 10.1016/j.bbrc.2017.07.161. Epub 2017 Jul 29.

PMID:
28765046
17.

Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes.

Pang Z, Kushiyama A, Sun J, Kikuchi T, Yamazaki H, Iwamoto Y, Koriyama H, Yoshida S, Shimamura M, Higuchi M, Kawano T, Takami Y, Rakugi H, Morishita R, Nakagami H.

FASEB J. 2017 Sep;31(9):4053-4063. doi: 10.1096/fj.201700110R. Epub 2017 May 25.

PMID:
28546444
18.

Autism spectrum disorder-associated genes and the development of dentate granule cells.

Ito H, Morishita R, Nagata KI.

Med Mol Morphol. 2017 Sep;50(3):123-129. doi: 10.1007/s00795-017-0161-z. Epub 2017 May 22. Review.

PMID:
28534217
19.

A novel lipoprotein (a) lowering drug, D-47, decreases neointima thickening after vascular injury.

Nakaya Y, Fukuda D, Oyamada T, Ogawa K, Harada N, Nakagami H, Morishita R, Sata M, Sakaue H.

J Med Invest. 2017;64(1.2):64-67. doi: 10.2152/jmi.64.64.

20.

Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress.

Wakayama K, Shimamura M, Suzuki JI, Watanabe R, Koriyama H, Akazawa H, Nakagami H, Mochizuki H, Isobe M, Morishita R.

Stroke. 2017 May;48(5):1362-1368. doi: 10.1161/STROKEAHA.116.016269. Epub 2017 Mar 31.

Supplemental Content

Loading ...
Support Center